Literature DB >> 2138950

Competition for binding sites on C3b by CR1, CR2, MCP, factor B and factor H.

T C Farries1, T Seya, R A Harrison, J P Atkinson.   

Abstract

The reaction of radiolabeled C3b-binding proteins with C3b-coated particles has been investigated. CR1 binding was inhibited by factor H and factor B (in the presence of properdin), but not by properdin alone. CR2 and MCP binding were also inhibited by factor H. Therefore factor H, factor B, CR1, CR2 and MCP probably comprise a group of mutually competitive proteins with similar or overlapping binding sites on C3b. These results correlate with their structural homology and suggest that they all evolved from a single C3b-binding molecule. Factor H, CR1 and MCP are also cofactors for the factor-I-mediated cleavage of C3b. A species incompatibility between rat factor I and human CR1 for the cleavage of human C3b suggests the possibility that cofactors may also function by interacting directly with factor I.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138950     DOI: 10.1159/000463124

Source DB:  PubMed          Journal:  Complement Inflamm        ISSN: 1012-8204


  16 in total

Review 1.  Viral-derived complement inhibitors: current status and potential role in immunomodulation.

Authors:  Hadi Abou-El-Hassan; Hassan Zaraket
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-26

2.  A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H.

Authors:  Sophie Chauvet; Lubka T Roumenina; Sarah Bruneau; Maria Chiara Marinozzi; Tania Rybkine; Elizabeth C Schramm; Anuja Java; John P Atkinson; Jean Claude Aldigier; Frank Bridoux; Guy Touchard; Veronique Fremeaux-Bacchi
Journal:  J Am Soc Nephrol       Date:  2015-10-15       Impact factor: 10.121

Review 3.  The complement system: history, pathways, cascade and inhibitors.

Authors:  P N Nesargikar; B Spiller; R Chavez
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-06-13

4.  Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3.

Authors:  Jason Twohig; Liudmila Kulik; Catherine Haluszczak; Jason Reuter; Andreas Rossbach; Melanie Bull; V Michael Holers; Kevin J Marchbank
Journal:  Mol Immunol       Date:  2007-03-26       Impact factor: 4.407

5.  Bacterial expression and membrane targeting of the rat complement regulator Crry: a new model anticomplement therapeutic.

Authors:  Deborah A Fraser; Claire L Harris; Richard A G Smith; B Paul Morgan
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

6.  Structural stability and heat-induced conformational change of two complement inhibitors: C4b-binding protein and factor H.

Authors:  Lena Kask; Bruno O Villoutreix; Mårten Steen; Bala Ramesh; Björn Dahlbäck; Anna M Blom
Journal:  Protein Sci       Date:  2004-04-09       Impact factor: 6.725

7.  Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.

Authors:  H P Huemer; Y Wang; P Garred; V Koistinen; S Oppermann
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

8.  The opportunistic human pathogenic fungus Aspergillus fumigatus evades the host complement system.

Authors:  Judith Behnsen; Andrea Hartmann; Jeannette Schmaler; Alexander Gehrke; Axel A Brakhage; Peter F Zipfel
Journal:  Infect Immun       Date:  2007-11-26       Impact factor: 3.441

9.  Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations.

Authors:  Azubuike I Okemefuna; Ruodan Nan; Ami Miller; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

10.  Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.

Authors:  M Krych; D Hourcade; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.